Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2)

Brief description of study

This is a randomized, open label, multicenter trial to evaluate the safety, dosing, efficacy and biological activity of intraperitoneal GEN-1 plus NACT compared to NACT alone.

Clinical Study Identifier: NCT03393884

Start Over

Women & Infants Hopsital of Rhode Island

Providence, RI United States

9.3miles

View all locations

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up now »

Powered by